Belpointe Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-415
Closed -$26K 2507
2023
Q1
$26K Buy
415
+120
+41% +$7.49K ﹤0.01% 2151
2022
Q4
$18.5K Buy
+295
New +$16.9K ﹤0.01% 2244

Other funds holding PBH

Belpointe Asset Management's PBH Position: Q2 2023 in Review

Belpointe Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2023, closing a stake of 415 shares — an estimated $26K sold.

Belpointe Asset Management first reported a position in PBH in Q4 2022 and held it in 2 quarters. The position peaked at $26K in Q1 2023. 279 funds tracked by Wall St. Rank hold PBH as of Q2 2023.

  • Belpointe Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 415 Prestige Consumer Healthcare shares in Q2 2023, an estimated $26K.
  • Belpointe Asset Management first reported a position in Prestige Consumer Healthcare in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Prestige Consumer Healthcare position peaked at $26K in Q1 2023.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.